# Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients

> **NCT01658839** · PHASE1 · COMPLETED · sponsor: **Alcon Research** · enrollment: 25 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost ophthalmic solution, 0.004% (new formulation)

## Key facts

- **NCT ID:** NCT01658839
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658839, "Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01658839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*